Ab&B Biotech
Taizhou
About Ab&B Biotech
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $10K – $50K
- Total funding: $92.7M
- Funding stage: IPO
- Last round: Series C (Jul 2021)
- Ticker: hkg:2627
- Website: abbbio.com
- Phone: 0523-82205899
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/ab-b-biotech-85390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.